| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 37.499 | 105.565 | 142.775 | 134.005 | 149.317 |
| Total Income - EUR | - | - | - | - | 0 | 38.288 | 106.342 | 145.914 | 143.342 | 149.345 |
| Total Expenses - EUR | - | - | - | - | 119 | 14.080 | 27.673 | 35.598 | 42.482 | 43.048 |
| Gross Profit/Loss - EUR | - | - | - | - | -119 | 24.209 | 78.669 | 110.316 | 100.860 | 106.297 |
| Net Profit/Loss - EUR | - | - | - | - | -119 | 23.841 | 77.727 | 108.964 | 99.565 | 102.041 |
| Employees | - | - | - | - | 0 | 2 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Diabclinic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 127 | 4.534 | 21.685 | 17.869 | 13.296 | 9.116 |
| Current Assets | - | - | - | - | 55 | 29.267 | 67.571 | 104.031 | 137.504 | 101.323 |
| Inventories | - | - | - | - | 13 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 2.014 | 83 | 13.901 | 6.852 | 70.779 |
| Cash | - | - | - | - | 42 | 27.252 | 67.488 | 90.129 | 130.652 | 30.544 |
| Shareholders Funds | - | - | - | - | -76 | 23.766 | 77.697 | 109.015 | 99.616 | 102.091 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 258 | 10.034 | 1.450 | 5.788 | 52.217 | 8.348 |
| Income in Advance | - | - | - | - | 0 | 0 | 10.108 | 7.097 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Diabclinic S.r.l.